DEFA14A: Supernus Pharmaceuticals Sets Date for Annual Stockholders Meeting, Outlines Key Proposals

Supernus Pharmaceuticals will hold its annual stockholders meeting virtually on June 14, 2024, to vote on director elections, executive compensation, auditor ratification, and an amendment to the equity incentive plan.

Summary

• Supernus Pharmaceuticals will hold its annual stockholders meeting on June 14, 2024.
• The meeting will be conducted virtually.
• Stockholders will vote on the election of two directors, Georges Gemayel and Bethany L. Sensenig, for three-year terms.
• A non-binding vote will be held to approve the compensation paid to named executive officers.
• Stockholders will vote to ratify the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• A proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan and make certain technical updates will be considered.
• The board of directors recommends voting FOR all listed nominees and Proposals 2, 3, and 4.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment as it reflects routine corporate governance processes.

Positives

• The company is providing stockholders with multiple avenues to access proxy materials and vote, including online, phone, and email.
• Stockholders have the option to receive future materials electronically, promoting environmental sustainability.

Future Outlook

The document outlines the proposals to be voted on at the annual meeting, indicating the company's focus on governance and executive compensation.

Industry Context

This announcement is a routine part of corporate governance, ensuring shareholders have the opportunity to participate in key decisions regarding the company's direction and management.

Corporate Governance

Stakeholder Impact

• Shareholders are directly impacted through their voting rights on key company decisions.
• Employees may be indirectly impacted by the vote on the equity incentive plan.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the annual meeting on June 14, 2024, and announce the results of the votes.

Key Dates

Keywords

Supernus Pharmaceuticals, stockholders meeting, proxy statement, annual meeting, corporate governance, directors, executive compensation, KPMG, equity incentive plan, voting